Health System

The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.

The state joins New York and Minnesota in providing COVID-19 vaccination access through pharmacy.

A panel has given a “weak recommendation” for the use of remdesivir in patients with severe coronavirus disease 2019.

Joshua Miller, MD MPH and medical director of diabetes care for Stony Brook Medicine, discusses continuous glucose monitoring (CGM) technology, which the FDA has authorized for use in hospitals amid the COVID-19 pandemic.

Here's this week's coronavirus-related news.

The American Society of Health-System Pharmacists (ASHP) announced plans to hold the 2020 Midyear Clinical Meeting in December as an all-virtual experience.

NACDS, APhA, NCPA, and others warn that overlooking DIR fee reform will be detrimental to pharmacy viability.

Experts will examine the prospects of several COVID-19 vaccine candidates that are entering phase 3 trials.

Here's this week's roundup of the coronavirus-related news you should know.

By adding an adjuvant to an existing vaccine treatment, it’s possible to optimize the body’s response to the presence of a virus.

An inside look at the process from prescription to dispensing.

In a letter to President Trump, NCPA CEO explained that failure to implement sweeping DIR fee reform would be detrimental to independent community pharmacies and their patients.

On May 8, 2020, the FDA granted accelerated approval to selpercatinib (Retevmo; Eli Lilly and Company).

Here's the coronavirus-related news you should know from this week.

A recent study found that the programs may result in cost savings to health systems and patients.

Enhanced pharmacy services such as home delivery, curbside services, and expanded personal patient outreach create opportunities to address social determinants of health during the pandemic.

In part 2 of our interview, Dr. Cheryl Wisseh, PharmD, MPH, zone 5 director, NPhA, dives into the forces that bring about racial disparities, and offers pharmacy and health system-centered solutions.

Sandoz is collaborating with Civica Rx to provide critical injectable generic medicines to hospitals to help reduce supply shortages.

Dr. Cheryl Wisseh, PharmD, zone 5 director of the National Pharmaceutical Association (NPhA) discusses the ways that the current pandemic is displaying and doubling down on long standing disparities in our health care system.

Here's the coronavirus-related news you should know from this week.

The annual survey hit on key health-system pharmacy insights related to formulary management, pharmacogenomics, and opioid stewardship, among others.

Drug Topics interviews Steve Mok, PharmD, BCPS, BCIDP, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence (AI) can mitigate challenges posed by the COVID-19 pandemic.

Here's this week's roundup of the coronavirus-related news you should know.

A collaboration between APhA and PTCB will help provide pharmacy technician credentialing in immunization delivery.

A new computer algorithm might be the next step toward accurate prediction of adverse drug reactions.

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

In an open letter, Gilead Chairman and CEO Daniel O’Day announced the price of remdesivir treatment for COVID-19.

Today, pharmacists are banding together to “eliminate racism, discrimination, injustice, and the marginalization of individuals within the profession.”

Check out this week's most important coronavirus-related news.

Existing surveillance networks can track influenza-like illness and lead to improved assessments on impact, prevalence, and severity of COVID-19.